Sensus Healthcare Stock Hits New 52-Week Low at $2.85

Sensus Healthcare, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 2.85 on May 8, 2026. This decline marks a significant downturn for the company, which has experienced a 43.8% drop in its stock price over the past year, contrasting sharply with the S&P 500's performance of 30.63% during the same period. The company's financial metrics reveal a challenging landscape, with net sales plummeting by 62.2% and a return on equity of -16.05%. Additionally, the stock's price-to-book ratio stands at 1.36, indicating potential valuation concerns. Sensus Healthcare's market capitalization is currently at USD 65 million, and it has not declared any dividends, reflecting its loss-making status. The stock's performance has been further impacted by a significant increase in raw material costs, which rose by 29.89% year-over-year. With these factors contributing to its current position, Sensus Healthcare continues to face a difficult market environment as it navigates through these financial challenges.